Hermetica Superfood Encyclopedia
The Short Answer
Albizia lebbeck is an Ayurvedic tree whose bark and leaves contain saponins and flavonoids with demonstrated antimalarial and anticancer properties. The saponin fraction exhibits cytotoxic effects against breast cancer cells while whole plant extracts show activity against malaria parasites.
CategoryHerbs (Global Traditional)
GroupAyurveda
Evidence LevelModerate
Primary KeywordAlbizia lebbeck benefits
Synergy Pairings3

Shirish (Albizia lebbeck) — botanical close-up
Health Benefits
Origin & History

Natural habitat
Shirish (Albizia lebbeck) is a deciduous tree native to tropical and subtropical regions, particularly India, where it has been used in traditional Ayurvedic medicine. The medicinal parts include bark, leaves, seeds, and roots, with extracts commonly prepared via Soxhlet extraction using ethanol or methanol.
“Albizia lebbeck has been used for centuries in Ayurvedic medicine for respiratory disorders, skin conditions, gastrointestinal issues, oral disorders, eye and urinary problems, snakebites, and as an antivenom. It is also utilized in other global traditional systems for anti-inflammatory, antidiabetic, wound healing, and antiallergic purposes.”Traditional Medicine
Scientific Research
Evidence for Shirish is limited to preclinical studies with no human clinical trials identified. Key animal studies include antimalarial effects in BALB/c mice (PMID: 26905234), anticancer activity in MCF-7 cells and chick embryo models (PMID: 30408535), and neuroprotection against glutamate toxicity in HMC3 microglial cells and cisplatin neuropathy in mice (PMID: 40974554).
Preparation & Dosage

Traditional preparation
Preclinical studies used: ethanolic bark extract 100-1000 mg/kg orally in mice for antimalarial effects; leaf extract 200-400 mg/kg orally for neuroprotection; saponin fractions 0.1-1 µg/ml in vitro for anticancer effects. No human dosage data available. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Shirish (Albizia lebbeck) is a medicinal plant rather than a dietary food source; its nutritional composition reflects its use as a bark, seed, pod, and leaf extract in Ayurvedic practice rather than macronutrient consumption. Key bioactive compounds include: (1) Saponins — macrocyclic triterpene saponins (lebbeckaside, albizziasaponins A–E) concentrated in bark and seeds, with saponin fractions showing bioactivity at IC50 ~1 µg/ml in cancer cell lines; (2) Flavonoids — quercetin, luteolin, and kaempferol glycosides identified in leaf and bark extracts; (3) Alkaloids — trace amounts including julibrosine-type alkaloids found in seeds; (4) Tannins — condensed and hydrolysable tannins present in bark (estimated 8–12% in dried bark by weight in phytochemical screenings); (5) Phenolic acids — gallic acid and ellagic acid derivatives; (6) Fixed oils in seeds containing oleic acid (~30%), linoleic acid (~20%), and palmitic acid (~15%) as primary fatty acids; (7) Crude protein in seeds approximately 25–30% dry weight, with amino acids including lysine, arginine, and leucine; (8) Crude fiber in pods approximately 15–20% dry weight; (9) Minerals detected in leaf and bark: calcium, potassium, magnesium, and iron in moderate quantities (specific concentrations vary by extraction method and plant part). Bioavailability note: Saponins may form complexes with cholesterol and bile acids in the gut, limiting direct absorption but enabling local GI activity; flavonoid glycosides require gut microbial deglycosylation for aglycone absorption; most pharmacological data derives from hydroalcoholic or aqueous extracts at doses of 200–400 mg/kg in rodent models, and human bioavailability data remains unpublished.
How It Works
Mechanism of Action
Albizia lebbeck's saponin compounds induce apoptosis in cancer cells through cytotoxic mechanisms, achieving IC50 values of 1 µg/ml in MCF-7 breast cancer cells. The plant's antimalarial activity appears to target Plasmodium parasites directly, with effective doses below 100 mg/kg in animal models. Additional flavonoid compounds may contribute to neuroprotective effects through antioxidant pathways.
Clinical Evidence
Research on Albizia lebbeck remains in preliminary stages with only in vitro and animal studies available. Mouse studies demonstrated antimalarial efficacy with ED50 values <100 mg/kg against Plasmodium berghei parasites. Laboratory studies showed the saponin fraction achieved IC50 1 µg/ml cytotoxicity against MCF-7 breast cancer cells. No human clinical trials have been conducted to establish safety or efficacy profiles in humans.
Safety & Interactions
Safety data for Albizia lebbeck in humans is limited due to lack of clinical trials. Traditional Ayurvedic use suggests general tolerability, but potential side effects and optimal dosing remain undefined. The plant may interact with antimalarial medications or chemotherapy drugs due to its bioactive compounds. Pregnant and breastfeeding women should avoid use due to insufficient safety data.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Albizia lebbeckLebbeck treeWoman's tongue treeSiris treeEast Indian walnutKokkoSaptaparniSirasKalba shirishShirishaBhandiKala siris
Frequently Asked Questions
What is the effective dose of Albizia lebbeck for antimalarial activity?
Animal studies show antimalarial effects at doses below 100 mg/kg body weight against Plasmodium berghei. However, human equivalent doses have not been established through clinical trials.
Which compounds in Albizia lebbeck provide anticancer effects?
The saponin fraction of Albizia lebbeck demonstrates anticancer activity with IC50 1 µg/ml against MCF-7 breast cancer cells. These saponin compounds appear to induce cell death through cytotoxic mechanisms.
Can Albizia lebbeck be used alongside malaria medications?
Potential interactions with antimalarial drugs are possible due to the plant's demonstrated antimalarial activity. Consult healthcare providers before combining with prescription antimalarial medications.
What parts of the Albizia lebbeck plant are used medicinally?
Both bark and leaves of Albizia lebbeck contain bioactive compounds used in traditional medicine. The saponin and flavonoid content varies between plant parts, with specific concentrations determining therapeutic potential.
Is Albizia lebbeck safe during pregnancy?
Safety during pregnancy has not been established through clinical studies. Due to the plant's bioactive compounds and potential effects on cellular processes, pregnant women should avoid use until safety data becomes available.
What is the quality of clinical evidence supporting Albizia lebbeck's health benefits?
Current evidence for Albizia lebbeck comes primarily from preliminary in vitro and animal studies, including mouse models showing antimalarial activity (ED50 <100 mg/kg against Plasmodium berghei) and neuroprotective effects against cisplatin-induced peripheral neuropathy at 200-400 mg/kg doses. Human clinical trials are limited, meaning efficacy and optimal dosing in people remain largely unestablished. More rigorous clinical research is needed before strong recommendations can be made for therapeutic use.
Does Albizia lebbeck interact with cancer treatment medications like chemotherapy?
Albizia lebbeck contains saponins that have shown anticancer activity in laboratory studies (IC50 1 µg/ml in MCF-7 breast cancer cells), but this same bioactivity raises theoretical concerns about potential interactions with chemotherapy drugs. Concurrent use with cisplatin or other cancer medications should be avoided or only undertaken under medical supervision, as the herb may interfere with drug efficacy or increase neurotoxicity risk. Always inform your oncologist before taking herbal supplements during cancer treatment.
Who is most likely to benefit from Albizia lebbeck supplementation based on traditional and emerging research?
Albizia lebbeck has been traditionally used in Ayurvedic medicine for respiratory and inflammatory conditions, and emerging research suggests potential benefits for individuals experiencing chemotherapy-related peripheral neuropathy or those in malaria-endemic regions with limited medication access. However, robust clinical evidence in specific populations remains lacking. Current use should be considered experimental and reserved for those under professional guidance rather than as a first-line therapy.

Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w shirish curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)